Targeting BRAF-mutant tumours with TGFBR1 inhibitors
Lindsay C. Spender1Division of Cancer Research, School of Medicine, University of Dundee, Dundee, UK, Gareth J. Inman1Division of Cancer Research, School of Medicine, University of Dundee, Dundee, UK
1Division of Cancer Research, School of Medicine, University of Dundee, Dundee, UK
Received: January 24, 2017Accepted: January 31, 2017Published: January 31, 2017